Skip to Content
Contact Form Map & Directions Videos

Author: Cal Warriner

Amylin Held Back Safety Data from FDA on Diabetes Drug

06/30/2012
Articles
BY

Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]

Read More

Metal Hip Implant Failure

06/27/2012
Defective Medical Devices
BY

The Searcy Denney Mass Tort Unit would like to thank our client, Howard Sadwin of Sarasota, Florida, for his poignant statements today before the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee for the Food and Drug Administration. The hearings were convened in Gaithersburg, Maryland.  In addition […]

Read More

Pradaxa Tops FDA’s List for Serious Adverse Events

06/26/2012
Articles
BY

According to an analysis by the Institute for Safe Medication Practices, Pradaxa drug (Dabigatran) topped the list of direct reports to the FDA for serious adverse drug events in 2011.  Pradaxa took the lead with 817 direct reports, followed by Coumadin (Warfarin) with 490 direct reports, Levaquin (Levofloxacin) with 393, […]

Read More

Hear What Our Clients Have To Say

"The attorneys and staff at Searcy Denney are some of the most compassionate and caring individuals I have met in the legal field. They work tirelessly on behalf of their clients to ensure the best possible outcome. I would highly recommend them for anyone who is seeking excellent legal representation."
Posted By: Lauren Schumacher